The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fauteux, L. J.
Right arrow Articles by Osmond, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fauteux, L. J.
Right arrow Articles by Osmond, D. G.

The Journal of Immunology, Vol 156, Issue 7 2376-2383, Copyright © 1996 by American Association of Immunologists


ARTICLES

IL-1 as systemic modifier of B lymphopoiesis. Recombinant IL-1 alpha binds to stromal cells and sinusoid endothelium in bone marrow and precursor B cell dynamics

LJ Fauteux and DG Osmond
Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada.

B lymphopoiesis in mouse bone marrow (BM) can be stimulated by circulating products derived from activated macrophages in the spleen. To examine whether IL-1 could mediate this effect, we have administered murine rIL-1alpha in a range of doses, determining its effect on precursor B cells and its capacity to bind to stromal cells in BM. Immunofluorescence labeling of terminal deoxynucleotidyl transferase (TdT), B220 glycoprotein, and mu-chains has been used to quantitate pro- B cells lacking mu (TdT+; 13220+mu-), pre-B cells expressing cytoplasmic mu, and B lymphocytes bearing surface mu. Proliferative activity was measured by mitotic arrest. Single i.p. injections of rIL- 1alpha produced a proliferative stimulation of pro-B cells and pre-B cells at optimal doses, whereas other doses were suppressive. Infusion of rIL-1alpha from s.c. osmotic pumps depressed B lymphopoiesis at high dose rates, but stimulated precursor B cell proliferation at lower dose rates. Intravenous 125I-labeled rIL-1alpha bound strongly to a subset of stromal reticular cells and sinusoidal endothelium in BM, as detected by light and electron microscope radio-autography. Computer- aided analysis located rIL-1alpha-binding stromal cells mainly in the outer zones of BM, sites of proliferating precursor B cells, rather than the more central zone. The results demonstrate that IL-1 can act systemically at various dose levels as either a positive or negative modifier of B lymphopoiesis in BM, probably acting indirectly via stromal reticular cells and endothelial cells. Thus, inflammatory processes associated with macrophage activation and IL-1 secretion may have pronounced effects on B cell genesis in BM.


This article has been cited by other articles:


Home page
J. Exp. Med.Home page
K. Nakamura, T. Kouro, P. W. Kincade, A. Malykhin, K. Maeda, and K. M. Coggeshall
Src Homology 2-containing 5-Inositol Phosphatase (SHIP) Suppresses an Early Stage of Lymphoid Cell Development through Elevated Interleukin-6 Production by Myeloid Cells in Bone Marrow
J. Exp. Med., January 20, 2004; 199(2): 243 - 254.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. L. Currier, M. Sicotte, and S. C. Miller
Deleterious effects of Echinacea purpurea and melatonin on myeloid cells in mouse spleen and bone marrow
J. Leukoc. Biol., August 1, 2001; 70(2): 274 - 276.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Lu, P. Chaudhury, and D. G. Osmond
Regulation of Cell Survival During B Lymphopoiesis: Apoptosis and Bcl-2/Bax Content of Precursor B Cells in Bone Marrow of Mice with Altered Expression of IL-7 and Recombinase-Activating Gene-2
J. Immunol., February 15, 1999; 162(4): 1931 - 1940.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.